Michael Habs

Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2′-dithio-bis-ethane sulfonate (dimesna)

Michael Habs, D. Schmähl · Cancer · 1983 · 61 citations

Medicine, Pharmacology, Pharmacotherapy +10

Form follows function: pragmatic controlled trials (PCTs) have to answer different questions and require different designs than randomized controlled trials (RCTs)

Franz Porzsolt, Martin Eisemann, Michael Habs et al. · Journal of Public Health · 2012 · 37 citations · Full text

Public Health, Public Health Practice, Causal Inference +15

Carcinogenicity of methapyrilene hydrochloride, mepyramine hydrochloride, thenyldiamine hydrochloride, and pyribenzamine hydrochloride in Sprague-Dawley rats

Michael Habs, Philippe Shubik, Gerhard Eisenbrand · Journal of Cancer Research and Clinical Oncology · 1986 · 32 citations · Full text

Pharmacy, Pharmacology, Toxicology +8

Prevention of cyclophosphamide-induced carcinogenesis in the urinary bladder of rats by administration of mesna

D. Schmähl, Michael Habs · Cancer Treatment Reviews · 1983 · 24 citations

Medicine, Pharmacology, Urology +7

Carcinogenic activity in rats of combined treatment with cyclophosphamide, methotrexate and 5‐fluorouracil

Michael Habs, D. Schmähl, Pengxin Lin · International Journal of Cancer · 1981 · 18 citations

Medicine, Oncology, Pharmacology +12